Lasofoxifene (Synonyms: CP 336,156) |
カタログ番号GC44036 |
ラソフォキシフェン (CP-336156) は、経口で活性な選択的エストロゲン受容体モジュレーター (SERM) です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 180916-16-9
Sample solution is provided at 25 µL, 10mM.
Lasofoxifene is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERα with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target.
Average Rating: 5
(Based on Reviews and 15 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *